Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by CytochromePon Jul 19, 2017 4:05pm
79 Views
Post# 26487449

RE:RE:RE:RE:RE:RE:RE:T.weed destroying aphria!

RE:RE:RE:RE:RE:RE:RE:T.weed destroying aphria!That's why you use many metrics, bais, I keep having to say bias. Use WACC, modify it, then use it. It will help you use multiple metrics all-in-one.

Aph EPS = Positive
Weed EPS = Negative 

Therefore Weed is bleeding money and wont survive. Amazing how I can take a different metric and turn your conclusion 180. (I was not making a serious comparison if it wasn't obvious enough)

TimMcCracken wrote:
CytochromeP wrote: Interesting, you think financial analysis uses a bised selection daily moving values to determine the performance of a company? If you're not embarrased, I will be embarrased for you. 

If you want to actually make a statement instead of continuing to make unfounded, biased statements you want to start by reading and using fianancial statements from both companies to come up with a model you want to use to compare them. If you need help send me a DM and I will help you sort out what metics to start with.

Grnhousegarbage wrote:
Fact, t.weed is outperforming aphria today. Fact, other then today aphria has outperformed short/mid term. Fact, not all companies in the space move in unison acb lagged for a long time under $.50 before making up and catching up to the rest. Fact, people can speculate but know one really knows who will be the industry leader in 5 years or which company will give it's investor the most gains. Fact, swing, day traders focus on short term gains. They may use growth potential and fundamentals in their decision making but they are concerned with short term gains not investing in long term growth of a company. Statement not hypothesis....

 



Cytochrome, 

I choose price to sales as my growth metric of choice. 

$APH;

Market Cap = $876,000,000
P/S = 38.5 x's on current sales assuming no growth 

$CGC; 

Market Cap = $1,380,000,000
P/S = 20.9 x's on current sales assuming no growth 

CGC investors currently pay $20.90 for every $1 in revenue while APH investors currently pay $38.50 for every $1 of revenue. 

This is only one of many metrics and like I said this is only my metric of choice, both companies deploy different strategies, both will likely continue to find ways to succeed. 

Regards, 

Tim 



Bullboard Posts